Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2005
05/04/2005EP1341539B1 Anti-inflammatory agents
05/04/2005EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors
05/04/2005EP1307471B1 16alpha-methyl or ethyl substituted estrogens
05/04/2005EP1305029A4 Method of increasing sensitivity of mammography
05/04/2005EP1296984B1 Pharmaceutical composition comprising a farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer
05/04/2005EP1259477B1 Aminoadamantane derivatives as therapeutic agents
05/04/2005EP1255546B1 Method for improving bone modeling and chondrocyte functioning in growing canines
05/04/2005EP1246790B1 Substituted 1 and 2 naphthol mannich bases
05/04/2005EP1242061B1 Use of bioactive metabolites of gepirone for the manufacture of a medicament for the treatment of psychological disorders
05/04/2005EP1240165B1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
05/04/2005EP1232148B1 Use of benzotriazole uv absorbers
05/04/2005EP1225895B1 Fab i inhibitors
05/04/2005EP1220676B1 Prevention of colorectal cancer
05/04/2005EP1218395B1 Antisense modulation of x-linked inhibitor of apoptosis expression
05/04/2005EP1214055B1 Pharmaceutical gel containing active substances
05/04/2005EP1206256B1 Combination therapy using pentafluorobenzenesulfonamide and platin compound
05/04/2005EP1180519B1 Hydrochloride of fused-heterocycle compound
05/04/2005EP1169029B1 Use of sibutramine or its derivative for the treatment of sleep disorders
05/04/2005EP1158973B1 Use of sulfamate derivatives for treating impulse control disorders
05/04/2005EP1156782B1 Echinocandin pharmaceutical formulations containing micelle-forming surfactants
05/04/2005EP1152762B1 Use of desoxypeganine in the treatment of alzheimer's dementia
05/04/2005EP1147103B1 Phenantrhridine-n-oxides with pde-iv inhibiting activity
05/04/2005EP1140830B1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives having 5ht1a receptor activity
05/04/2005EP1140017B9 Water-insoluble drug delivery system
05/04/2005EP1140001B1 Composition for treatment of burns
05/04/2005EP1139752B1 Methods and compositions for treatment of cell proliferative disorders
05/04/2005EP1127057B1 Naphthyridine compounds and thier azaisosteric analogues as antibacterials
05/04/2005EP1124810B1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/04/2005EP1119567B1 Quinazoline derivatives
05/04/2005EP1109812B1 Pyrrolobenzodiazepines
05/04/2005EP1094790B9 Sustained release pharmaceutical preparation comprising phenytoin sodium
05/04/2005EP1061955B1 Polynucleotide composition, method of preparation, and use thereof
05/04/2005EP1032368B1 Iontophoretic devices comprising piperidin derivatives
05/04/2005EP1023067B1 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
05/04/2005EP0958280B1 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same
05/04/2005EP0946177B1 METHOD OF INHIBITING BIOSYNTHESIS OF EIf5A
05/04/2005EP0941227B9 Epothilone d, production process, and its use as cytostatic as well as phytosanitary agent
05/04/2005EP0886637B9 Inhibitors of microsomal triglyceride transfer protein and method
05/04/2005EP0882048B1 3-alkylimidazopyridines
05/04/2005EP0825858B1 Time-dependant release capsules containing omega-3 polyunsaturated acids for the treatment of inflammatory bowel disease
05/04/2005EP0815099B1 Tricyclic amide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
05/04/2005CN2696635Y Vagina suppository and settling device for controlling estrous cycle of ewe
05/04/2005CN1613012A Soluble cd40l (cd154) as a prognostic marker of atherosclerotic diseases
05/04/2005CN1612941A Methods of treating psychosis and schizophrenia based on polymorphisms in the CNTF gene
05/04/2005CN1612890A Novel chimeric tnf ligands
05/04/2005CN1612889A 3-b-d-ribofuranosylthiazolo [4, 5-d] pyridimine nucleosides and uses thereof
05/04/2005CN1612888A Macrolides
05/04/2005CN1612878A Synthesis and purification of valacyclovir
05/04/2005CN1612877A Spiroazacyclic compounds as monoamine receptor modulators
05/04/2005CN1612876A Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1] octane, the preparation thereof and the application of same in therapeutics
05/04/2005CN1612875A 5-(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thereof; and its use as pharmaceutical active
05/04/2005CN1612874A Rosiglitazone edisylates and their use as antidiabetics
05/04/2005CN1612873A 4-2-n-methyl-n-2-pyridylamidoethoxybenzylthiazolidine-2, 4-dione and pharmaceutical compositions comprising the same
05/04/2005CN1612872A Process for the preparation of simvastatin
05/04/2005CN1612869A Novel 1, 2, 4-thiadiazolium derivatives as melanocortin receptor modulators
05/04/2005CN1612868A Ethylene derivative and use as phophatidase
05/04/2005CN1612866A Amorphous and crystalline forms of losartan potassium and process for their preparation
05/04/2005CN1612865A Triazole derivatives as cyclooxygenase (COX) inhibitors
05/04/2005CN1612864A Novel alkansulfonamides as endothelin antagonists
05/04/2005CN1612863A Deuterated substituted pyrazolylbenzylsulfonamides pharmaceutical compositions containing them and use thereof
05/04/2005CN1612862A Preparation of an anhydrous quinoline-based EETP inhibitor by crystallization
05/04/2005CN1612859A Crystalline (r-(r*, r*))-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1h-pyrrole-heptanoic acid calcium salt (2:1)
05/04/2005CN1612856A 1, 3-diarylprop-2-en-1-ones, compositions containing same and use thereof
05/04/2005CN1612855A Methods of reversing and preventing cardiovascular pathologies
05/04/2005CN1612852A Lipoxin A4 analogs
05/04/2005CN1612763A Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
05/04/2005CN1612751A Combination treatments for allergic disease comprising administering an anti-IgE antibody and antiallergic compound
05/04/2005CN1612745A Methods for slowing senescence and treating and preventing diseases associated with senescence
05/04/2005CN1612743A Herbal composition phy906 and its use in chemotheraphy
05/04/2005CN1612741A Use of sulfated glycosaminoglycans for establishing effective labor in women
05/04/2005CN1612740A Cardiac arrest fluid
05/04/2005CN1612739A Method for treating or preventing inflammatory diseases
05/04/2005CN1612738A Combination therapy comprising ZD6474 and a taxane
05/04/2005CN1612737A Platinum derivative pharmaceutical formulations
05/04/2005CN1612736A Imidazo (4, 3-e)-1, 2, 4-triazolo(1, 5-c) pyrimidines as adenosine A2A receptor antagonists
05/04/2005CN1612735A Uses for anti-malarial therapeutic agents
05/04/2005CN1612734A Aqueous liquid preparations and light-stabilized aqueous liquid preparations
05/04/2005CN1612733A Benzimidazoles useful as protein kinase inhibitors
05/04/2005CN1612732A Analgesics and methods of use
05/04/2005CN1612731A Composition inhibiting matrix-metallproteinases for the treatmentof neoplastic diseases
05/04/2005CN1612730A Medicinal composition containing 2, 2-dichloro-12-(4-chlorophenyl)dodecanoic acid
05/04/2005CN1612729A 2-aryl-propionic acid and medicine composition containing same
05/04/2005CN1612728A Method and pharmaceutical preparations for reducing the activity of cells
05/04/2005CN1612727A Stable granulates containing S-adenosylmethionine and process for the preparation thereof
05/04/2005CN1612724A Vascular occlusion solid-phase agent with immobilised platelet binding agent
05/04/2005CN1612723A Local compositions containing enzymes stabilized with inhibitors
05/04/2005CN1612698A Modified methionine rich food products and process for their manufacture
05/04/2005CN1611603A Novel DNA fragment and its inhibition from tumour
05/04/2005CN1611509A Nucleic acid adaptor for specific identifying human cerebral acetylcholinesterase and its use
05/04/2005CN1611505A Novel 9-nitro campotothecin crystal form and medicinal composition
05/04/2005CN1611500A 3-aryl-Beta-carboline-1-ketone compound, and its preparing method and use
05/04/2005CN1611499A Heterocyclic compounds as inhibitors of rotamase enzymes
05/04/2005CN1611497A Anti-AIDS virus active substance desmosdumotin D and desmosdumotin and its analogue
05/04/2005CN1611489A Intermediates for the synthesis of benzimidazole compounds and process for preparation thereof
05/04/2005CN1611260A Combined medicine of adefovir dipivoxil
05/04/2005CN1611226A CMSVP beauty and free-radical removing function
05/04/2005CN1611225A Swallow foot beauty and free radical cleaning function
05/04/2005CN1611224A Compound preparation of notoginseng total saponin and quzaqi aglycone and its preparing method
05/04/2005CN1611223A Sulfony lated acetylglucosamine medicinal composition and its use
05/04/2005CN1611222A Composition for contraception
1 ... 4703 4704 4705 4706 4707 4708 4709 4710 4711 4712 4713 4714 4715 4716 4717 4718 4719 4720 4721 4722 4723 ... 7860